Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

about

Inhibition of protein kinase CK2 sensitizes non-small cell lung cancer cells to cisplatin via upregulation of PML.

P2860

Q48026912-35589F92-E3DE-475F-A304-CD9DCD7EA470

P2860

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

Item

http://www.wikidata.org/entity/Q26769590

description

2015 nî lūn-bûn

@nan

2015 թուականին հրատարակուած գիտական յօդուած

@hyw

2015 թվականին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@ast

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@en

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@nl

type

Item

label

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@ast

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@en

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@nl

prefLabel

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@ast

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@en

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@nl

P1476

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

@en

P2093

Angelo Guerrasio

http://www.w3.org/2001/XMLSchema#string

Sabrina Crivellaro

http://www.w3.org/2001/XMLSchema#string

P2860

The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region

Phosphorylation of the PTEN tail regulates protein stability and function

The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation

Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia

Protein kinase CK2 inhibition is associated with the destabilization of HIF-1α in human cancer cells

Globozoospermia in mice lacking the casein kinase II alpha' catalytic subunit

Direct identification of PTEN phosphorylation sites

Rational approaches to the design of therapeutics targeting molecular markers: the case of chronic myelogenous leukemia

The functions and regulation of the PTEN tumour suppressor

Design, validation and efficacy of bisubstrate inhibitors specifically affecting ecto-CK2 kinase activity.

P304

612567

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2015/612567

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2015

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

288832816

http://www.w3.org/2001/XMLSchema#string

P698

26843864

http://www.w3.org/2001/XMLSchema#string

P932

4710905

http://www.w3.org/2001/XMLSchema#string

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

about

P2860

P2860

Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932